Integrating Digital and Ancillary Technologies in the Modern Clinical Evaluation of Chorea

Ethical Compliance Statement: The authors confirm that the approval of an institutional review board was not required for this work. Informed consent was not required, as this study did not involve any human participants. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Declaration of patient consent: Not applicable. No patients or human participants were involved in this study. Funding Sources and Conflict of Interest: No specific funding was received for this work. The authors declare no conflicts of interest relevant to this work. Financial Disclosures for the previous 12 months: GS has received research and CME support from the Michael J. Fox Foundation through the Global Parkinson's Genetics Program (GP2) (MJFF-026331), and speaker's honoraria and CME support from various pharmaceutical companies in the Philippines (in alphabetical order): AbbVie Inc., Bharat Serums And Vaccines Limited (BSV), Cathay Drug Company Inc., DKSH Philippines, E* Chimes Pharmaceutical Inc., Haleon Philippines (GlaxoSmithKline Consumer Healthcare Philippines), HI-Eisai Pharmaceutical, Inc., Hizon Laboratories, Inc., InnoGen Pharmaceuticals Inc, LRI-Therapharma, Lotus Pharmaceutical, Lundbeck Philippines, Inc., Medchoice Pharma Inc., Medichem Pharmaceutical Inc., Medtronic Philippines Inc., Menarini Philippines, Inc., Nestlé Philippines, Inc., One Pharma Marketing Inc., Pfizer Philippines Inc., Sandoz Philippines Corp., Sun Pharma Philippines, Torrent Pharma Philippines, Inc., Vexxa Lifesciences, and Zydus Healthcare Philippines Inc. received research support from the Michael J. Fox Foundation through the Global Parkinson's Genetics Program (GP2) and speaker's honoraria from various pharmaceutical companies in the Philippines. C-HL has received research support from research funding from the National Health Research Institutes (NHRI-EX114-11407NI). The data that supports the findings of this study are available in the supplementary material of this article. Figure S1. Modern phenomenology: a collaborative approach combining conventional clinical assessments and ancillary and digital tools. Conventional clinical methods (eg, clinical-based assessments, rating scales) utilize human expertise and contextual judgment, offering holistic patient interaction, but are prone to subjective assessments and accessibility challenges. Artificial intelligence and digital tools enhance diagnostic accuracy and scalability yet face limitations such as data reliability and ethical concerns. Modern phenomenology integrates both approaches to provide more precise and personalized patient care. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.